Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | BTK | Q06187 | 8/20 | 0.51 |
| ▸ | CLK2 | P49760 | 1/20 | 0.51 |
| ▸ | SRC | P12931 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TYK2 | P29597 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL609572 | 1.00 | KDM4E (0.56) | KDM4ERAB9ABTKCLK2SRC | |
| SCHEMBL610958 | 0.92 | HPGD (0.57) | KDM4ERAB9ABTKHPGDTYK2 | |
| SCHEMBL15906434 | 0.90 | FASN (0.51) | BTKHPGDGRM5 | |
| SCHEMBL12602961 | 0.90 | GRM5 (0.60) | KDM4ERAB9AHPGDTYK2GRM5 | |
| SCHEMBL12650334 | 0.89 | KDM4E (0.59) | KDM4ERAB9ABTKCLK2SRC | |
| SCHEMBL608992 | 0.87 | HPGD (0.48) | KDM4ERAB9ABTKHPGDGRM5 | |
| SCHEMBL14926081 | 0.86 | KDM4E (0.54) | KDM4ERAB9ABTKCLK2SRC | |
| SCHEMBL14926077 | 0.85 | GRM5 (0.46) | KDM4ERAB9ABTKCLK2HPGD | |
| SCHEMBL14926064 | 0.85 | GRM5 (0.46) | KDM4ERAB9ABTKCLK2HPGD | |
| SCHEMBL15906433 | 0.85 | GRM5 (0.49) | KDM4ERAB9ABTKHPGDGRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4050012-A1 | PYRIDONE BORONATES FOR THE PREPARATION OF INHIBITORS OF BTK ACTIVITY | F. Hoffmann-La Roche AG (CH) | 2022-08-31 | — | — | EP | disclosed |